EFFECT OF AZITHROMYCIN ON MACROPHAGE PHENOTYPE DURING PULMONARY INFECTIONS AND CYSTIC FIBROSIS
Azithromycin improves clinical outcomes in patients with cystic fibrosis (CF), specifically in patients infected with Pseudomonas aeruginosa. Azithromycin shifts macrophage programming away from a pro-inflammatory classical (M1) phenotype, and towards an anti-inflammatory alternative (M2) phenotype;...
Main Author: | |
---|---|
Format: | Others |
Published: |
UKnowledge
2011
|
Subjects: | |
Online Access: | http://uknowledge.uky.edu/gradschool_diss/834 http://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1836&context=gradschool_diss |